新華文軒(601811.SH):控股股東名稱及經營範圍變更完畢
格隆匯8月14日丨新華文軒(601811.SH)公佈,公司於2020年8月13日收到公司控股股東通知,經四川省市場監督管理局核准,控股股東已於2020年8月13日完成企業名稱及經營範圍變更登記,變更後基本信息如下:
名稱:四川新華出版發行集團有限公司
經營範圍:出版企業管理服務;電影和影視節目製作、發行;軟件開發、數字內容服務;房地產業;項目投資(不得從事非法集資、吸收公眾資金等金融活動)租賃業;會議及展覽服務;知識產權服務;商品批發與零售;娛樂業;住宿和餐飲業。(以上項目不含前置許可項目,後置許可項目憑許可證或審批文件經營)(依法須經批准的項目,經相關部門批准後方可開展經營活動)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.